The global vital organs support systems and medical bionics market size in 2017 is $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 10.9% from 2018 to 2025. An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addition to the body. These artificial implants mimic the function of the lost or nonfunctional body part.
The vital organs support systems and medical bionics market is expected to exhibit significant growth during the forecast period due to rise in geriatric population, scarcity of donor organs, technological advancements in the artificial organ sector, and increase in R&D expenditure. In addition, rise in number of patients suffering from chronic diseases drives the market growth. However, high cost of artificial organs and stringent approval process are projected to impede growth of the vital organs support systems and medical bionics market. On the contrary, application of advanced biomaterials in artificial organs and lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.
Get Free Sample Copy of Report @ https://www.qurateresearch.com/report/sample/HnM/QBI-AMR-HnM-440378
The global vital organs support systems and medical bionics market is segmented based on product, end user, and region. Depending on product, the market is categorized into vital organs support systems and medical bionics. The vital organs support systems segment is further divided into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. Depending on end user, the market is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
• By Product
Vital organs support systems
Artificial Urinary Bladder
Bone Anchored Hearing Systems
Auditory Brainstem Implants
• Bionic Knee
• Bionic Feet
Electrical Bone Growth Stimulators
• Non-Invasive Bone Growth Stimulators
• Invasive Bone Growth Stimulators
• Implantable Pacemaker
• External Pacemaker
Ventricular Assist Device
• Left Ventricular Assist Device (LVAD)
• Right Ventricular Assist Device (RVAD)
• Biventricular Assist Device (BIVAD)
Artificial Heart Valves
• Mechanical Heart Valves
• Tissue Heart Valves
• Deep Brain Stimulators (DBS)
• Sacral Nerve Stimulators (SNS)
• Vagus Nerve Stimulators (VNS)
• Spinal Cord Stimulators (SCS)
• Other Neurostimulators
External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
• By End User
Ambulatory Surgical Centers
• By Region
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Saudi Arabia
• South Africa
• Rest of LAMEA
For more information/ Ask your queries @ https://www.qurateresearch.com/report/enquiry/HnM/QBI-AMR-HnM-440378
KEY MARKET PLAYERS
• Abiomed, Inc.
• Abbott Laboratories
• Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
• Baxter International Inc.
• Boston Scientific Corporation
• Cochlear Ltd.
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• Medtronic Plc.
• Össur Americas, Inc.
• Second Sight Medical Products, Inc.
• SynCardia Systems LLC
The other players in the value chain include (profiles not included in the report):
• Getinge AB
• LivaNova PLC
• Fresenius Medical Care AG & Co. KGaA
• Heartware International Inc.
Table of Content:
CHAPTER 1 INTRODUCTION
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.2.3. Top winning strategies
18.104.22.168. Top winning strategies, by year 2014-2017
22.214.171.124. Top winning strategies, by development 2014-2017
126.96.36.199. Top winning strategies, by company 2014-2017
3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. KEY PLAYER POSITIONING, 2016
3.5. MARKET DYNAMICS
188.8.131.52. Rising need to track and manage income
184.108.40.206. Increasing dependency on internet
220.127.116.11. Increasing use of mobile applications
18.104.22.168. Availability of open-source solutions
22.214.171.124. Increased adoption of Vital Organs Support Systems and Medical Bionics among developing economies
CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET BY GEOGRAPHY
CHAPTER 7: COMPANY PROFILES
CHAPTER 8: COMPANY PROFILES
Place Purchase Order for this Report @ https://www.qurateresearch.com/report/buy/HnM/QBI-AMR-HnM-440378/